Atea Pharmaceuticals
AVIR
#7564
Rank
โ‚ฌ0.26 B
Marketcap
3,10ย โ‚ฌ
Share price
2.85%
Change (1 day)
17.99%
Change (1 year)

EPS for Atea Pharmaceuticals (AVIR)

EPS in 2023 (TTM): -1,19ย โ‚ฌ

According to Atea Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,22ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,34ย โ‚ฌ a decrease over its 2021 EPS that were of 1,39ย โ‚ฌ.

EPS history for Atea Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,19ย โ‚ฌ-10.85%
2022-1,34ย โ‚ฌ-195.89%
20211,39ย โ‚ฌ-645.91%
2020-0,26ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,08ย โ‚ฌ 70.31%๐Ÿ‡บ๐Ÿ‡ธ USA